PharmaCyte Biotech Inc (PMCB)

[1234jklm]

I agree something is happening and this new agreement seems to confirm this.


It's just not a fair deal to pcmb shareholders.
'We already have a license from sg Austria for the use of ciab for diabetes, cancer and cabbinoids at a 10% share of profits.

We paid 2 million for this and it's a good deal. We've also been paying for kw to get this done which is to Austria sg's benefit.

Why are we now changing that to 50% from 90% ?

So we get first right of refusal to buy the process and intellectual property?

Why do we want that when we already have a license that protects our interests?

And why do we have to pay 50% of our profits for a right we might never be able to use.

Look at it this way.

If Austria doesn't decide to sel,l this agreement still gives them 50% of profits forever. Huh?

It's simply a last minute renegotiation of how much profit we both get. Up from 10% to 50% for them. Down from 90% to 50% for us.. Simple as that.

So they get 50% even if nothing changes. So why make a deal where we lose out so badly?
'
This is an agreement that increases Austria sg's share of the pie with a big big loss to us.

And hey we own 14.5% of shares of Austria SG but as it's a private company how do we ever get our 14.5% share of their profits?

If we bought ciab that would allow austrianova to walk away from their responsibilities to produce ciab at our agreed price per batch and still get 50% of our profits. Great for them. Terrible for us. We already paid for that so don't take our rights away from us.

I say stay with the deal we have.

Austria sg were meant to produce our cell banks for an agreed fee. Why isn't that happening? That's part of the reason we paid them 2 million.

And if we buy the ciab, Austria gets the rights to bacbank so we don't even own the whole process or intellectual rights. And why exclude that?

To me this just seems like the bio blue bird renegotiated agreement with Austria sg where we lost stem cells and other uses for no big advantage to pcmb shareholders. That was a big loss to shareholders because stem cells and ciab could be bigger than diabetes and cancer.

My point is simply why change a good deal we have for a deal where we get much less and they get more.

Why are we paying them 900,000 of our cash over the next six months? For a right that might never be exercised? Huh?

Some think this new agreement is because some big pharma wants this to make a deal with us.

If that's the case we could make the same deal for 10% of profits to respect the agreement we already have.

Yes it looks like this is getting closer and to me this looks like an 11th hour grab for more of our profits.

Please don't attack me personally. I don't short stocks. I just say it like I see it. And I believe shareholders rights should be respected.

Don't shoot the messenger on this. Take a good close look at where the money is going and you'll see this looks like a huge win for so Austria and a big loss for us as shareholders.

Yes it looks like a deal is in the table.

Yes it looks like Austria sg is getting more of it than they agreed.